210 related articles for article (PubMed ID: 19536445)
1. The revolving door phenomenon in psychiatry: comparing low-frequency and high-frequency users of psychiatric inpatient services in a developing country.
Botha UA; Koen L; Joska JA; Parker JS; Horn N; Hering LM; Oosthuizen PP
Soc Psychiatry Psychiatr Epidemiol; 2010 Apr; 45(4):461-8. PubMed ID: 19536445
[TBL] [Abstract][Full Text] [Related]
2. Crisis discharges and readmission risk in acute psychiatric male inpatients.
Niehaus DJ; Koen L; Galal U; Dhansay K; Oosthuizen PP; Emsley RA; Jordaan E
BMC Psychiatry; 2008 Jun; 8():44. PubMed ID: 18559078
[TBL] [Abstract][Full Text] [Related]
3. Identifying patterns in psychiatric hospital stays with statistical methods: towards a typology of post-deinstitutionalization hospitalization trajectories.
Golay P; Morandi S; Conus P; Bonsack C
Soc Psychiatry Psychiatr Epidemiol; 2019 Nov; 54(11):1411-1417. PubMed ID: 31041468
[TBL] [Abstract][Full Text] [Related]
4. Assessing predictive factors for extended hospitalization at acute psychiatric admission.
Hopko DR; Lachar D; Bailley SE; Varner RV
Psychiatr Serv; 2001 Oct; 52(10):1367-73. PubMed ID: 11585954
[TBL] [Abstract][Full Text] [Related]
5. Predicting the "revolving door" phenomenon among patients with schizophrenic, schizoaffective, and affective disorders.
Haywood TW; Kravitz HM; Grossman LS; Cavanaugh JL; Davis JM; Lewis DA
Am J Psychiatry; 1995 Jun; 152(6):856-61. PubMed ID: 7755114
[TBL] [Abstract][Full Text] [Related]
6. Changes in the utilization of psychiatric hospital facilities in Denmark by patients diagnosed with schizophrenia from 1970 through 2012: The advent of 'revolving door' patients.
Jeppesen RM; Christensen T; Vestergaard CH
Acta Psychiatr Scand; 2016 May; 133(5):419-25. PubMed ID: 26748617
[TBL] [Abstract][Full Text] [Related]
7. Excessive antipsychotic dosing in 2 U.S. State hospitals.
Diaz FJ; De Leon J
J Clin Psychiatry; 2002 Nov; 63(11):998-1003. PubMed ID: 12444813
[TBL] [Abstract][Full Text] [Related]
8. Treatment of schizophrenia with depot preparations of fluphenazine, haloperidol, and risperidone among inpatients at state-operated psychiatric facilities.
Citrome L; Jaffe A; Levine J
Schizophr Res; 2010 Jun; 119(1-3):153-9. PubMed ID: 20347267
[TBL] [Abstract][Full Text] [Related]
9. Assessing the efficacy of a modified assertive community-based treatment programme in a developing country.
Botha UA; Koen L; Joska JA; Hering LM; Oosthuizen PP
BMC Psychiatry; 2010 Sep; 10():73. PubMed ID: 20843301
[TBL] [Abstract][Full Text] [Related]
10. [Long-acting injectable risperidone: naturalistic study in three hospitals in Aquitaine].
Raignoux C; Dusouchet T; Bret P; Queuille E; Biscay ML; Caron J; Bret MC
Encephale; 2007 Dec; 33(6):973-81. PubMed ID: 18789790
[TBL] [Abstract][Full Text] [Related]
11. [Prescribing patterns of antipsychotics in 13 French psychiatric hospitals].
Bret P; Bret MC; Queuille E
Encephale; 2009 Apr; 35(2):129-38. PubMed ID: 19393381
[TBL] [Abstract][Full Text] [Related]
12. Revolving-door patients in a public psychiatric hospital in Israel: cross sectional study.
Oyffe I; Kurs R; Gelkopf M; Melamed Y; Bleich A
Croat Med J; 2009 Dec; 50(6):575-82. PubMed ID: 20017226
[TBL] [Abstract][Full Text] [Related]
13. Do Long-Acting Injectable Antipsychotics Prevent or Delay Hospital Readmission?
Maestri TJ; Mican LM; Rozea H; Barner JC
Psychopharmacol Bull; 2018 Mar; 48(3):8-15. PubMed ID: 29713100
[TBL] [Abstract][Full Text] [Related]
14. Remission in prognosis of functional outcome: a new dimension in the treatment of patients with psychotic disorders.
Helldin L; Kane JM; Karilampi U; Norlander T; Archer T
Schizophr Res; 2007 Jul; 93(1-3):160-8. PubMed ID: 17395430
[TBL] [Abstract][Full Text] [Related]
15. Assessment of inpatient psychiatric readmission risk among patients discharged on an antipsychotic polypharmacy regimen: A retrospective cohort study.
Boskailo E; Malkoc A; McCurry DB; Venter J; Drachman D; Ramos GM
Acta Med Acad; 2017 Nov; 46(2):133-144. PubMed ID: 29338277
[TBL] [Abstract][Full Text] [Related]
16. [Rationale for the use of long-acting injectable risperidone: a survey of French psychiatrists].
Misdrahi D; Delgado A; Bouju S; Comet D; Chiariny JF
Encephale; 2013 May; 39 Suppl 1():S8-14. PubMed ID: 23541914
[TBL] [Abstract][Full Text] [Related]
17. Oral versus injectable antipsychotic treatment in early psychosis: post hoc comparison of two studies.
Emsley R; Oosthuizen P; Koen L; Niehaus DJ; Medori R; Rabinowitz J
Clin Ther; 2008 Dec; 30(12):2378-86. PubMed ID: 19167596
[TBL] [Abstract][Full Text] [Related]
18. Early clinical experience with risperidone long-acting injection: a prospective, 6-month follow-up of 100 patients.
Taylor DM; Young CL; Mace S; Patel MX
J Clin Psychiatry; 2004 Aug; 65(8):1076-83. PubMed ID: 15323592
[TBL] [Abstract][Full Text] [Related]
19. Predicting the revolving door phenomenon among patients with schizophrenic, affective disorders and non-organic psychoses.
Gastal FL; Andreoli SB; Quintana MI; Almeida Gameiro M; Leite SO; McGrath J
Rev Saude Publica; 2000 Jun; 34(3):280-5. PubMed ID: 10920451
[TBL] [Abstract][Full Text] [Related]
20. Early non-adherence to medication and other risk factors for rehospitalization in schizophrenia and schizoaffective disorder.
Bodén R; Brandt L; Kieler H; Andersen M; Reutfors J
Schizophr Res; 2011 Dec; 133(1-3):36-41. PubMed ID: 21982098
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
